Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Clavulanate |
Is a |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Clavulanate potassium (substance) |
Is a |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Product containing clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Product containing clavulanic acid and ticarcillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Ticarcillin 3g/clavulanic acid 100mg powder for injection solution vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Ticarcillin+clavulanic acid 3g/0.1g infusion 100mL bag |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Ticarcillin and clavulanic acid adverse reaction |
Causative agent (attribute) |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Allergy to ticarcillin and clavulanic acid |
Causative agent (attribute) |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Amoxicillin and clavulanate |
Is a |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing amoxicillin and clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Clavulanate potassium (substance) |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Amoxicillin and clavulanate |
This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
|
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Amoxicillin (as amoxicillin sodium) 1 g and clavulanic acid (as clavulanate potassium) 200 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clavulanic acid (as clavulanate potassium) 200 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing amoxicillin and clavulanic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing amoxicillin and clavulanic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Clavulanic acid- and ticarcillin-containing product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing only clavulanic acid and ticarcillin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only amoxicillin and clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Clavulanic acid and ticarcillin only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin and clavulanic acid only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only amoxicillin and clavulanic acid in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Allergy to ticarcillin and clavulanic acid |
Causative agent (attribute) |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin 125 mg and clavulanic acid (as clavulanate potassium) 31.2 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely clavulanic acid (as clavulanate potassium) 1 milligram and ticarcillin (as ticarcillin disodium) 30 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 120 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 8.58 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 250 milligram and clavulanic acid (as clavulanate potassium) 62.5 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin anhydrous (as amoxicillin) 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 250 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin trihydrate) 875 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 25 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 6.25 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin 500 mg and clavulanic acid (as clavulanate potassium) 125 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 80 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 11.4 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 50 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 12.5 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 100 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely clavulanic acid (as clavulanate potassium) 100 milligram and ticarcillin (as ticarcillin disodium) 3 gram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin 400 mg and clavulanic acid (as clavulanate potassium) 57 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release chewable tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin 250 mg and clavulanic acid (as clavulanate potassium) 62.5 mg chewable tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 40 milligram/1 milliliter and clavulanic acid (as clavulanate potassium) 5.7 milligram/1 milliliter conventional release oral suspension (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin 120 mg/mL and clavulanic acid (as clavulanate potassium) 8.58 mg/mL oral suspension |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin (as amoxicillin sodium) 250 mg and clavulanic acid (as clavulanate potassium) 50 mg powder for solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing cefuroxime and clavulanic acid (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Cefuroxime and clavulanic acid only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing cefuroxime and clavulanic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing only cefuroxime and clavulanic acid in oral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely cefuroxime (as cefuroxime axetil) 500 milligram and clavulanic acid (as clavulanate potassium) 125 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 200 milligram and clavulanic acid (as clavulanate potassium) 28.5 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin 400 milligram and clavulanic acid (as clavulanate potassium) 57 milligram/1 each conventional release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for infusion and/or injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Product containing precisely amoxicillin (as amoxicillin sodium) 500 milligram and clavulanic acid (as clavulanate potassium) 50 milligram/1 vial powder for conventional release solution for injection (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |
Amoxicillin and clavulanic acid therapy |
Direct substance |
True |
Clavulanic acid (substance) |
Inferred relationship |
Some |
2 |